Compare CGC & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGC | EMBC |
|---|---|---|
| Founded | N/A | 1924 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 354.1M |
| IPO Year | 2023 | 2021 |
| Metric | CGC | EMBC |
|---|---|---|
| Price | $0.43 | $6.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 2.5M | 719.9K |
| Earning Date | 11-06-2026 | 11-24-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | ★ 84.17 | 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $12,759,000.00 | N/A |
| Revenue This Year | $18.91 | N/A |
| Revenue Next Year | $6.82 | $5.59 |
| P/E Ratio | ★ N/A | $6.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $2.77 |
| 52 Week High | $2.38 | $14.78 |
| Indicator | CGC | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 19.41 | 43.28 |
| Support Level | N/A | $5.64 |
| Resistance Level | $1.08 | $6.85 |
| Average True Range (ATR) | 0.05 | 0.36 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 0.54 | 19.31 |
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.